Rectal neuroendocrine tumors (NETs) account for approximately one-third of all digestive
NETs, with an increasing incidence and good overall prognosis. Although recent guidelines
have been published, endoscopic techniques have expanded substantially and the most
recent reports should be taken into account for clinical practice. The objectives
of this report were to review the latest advances on prognosis, pre-interventional
explorations, treatment – with particular focus on endoscopy – and surveillance of
well-differentiated rectal NETs, excluding poorly differentiated and metastatic tumors.